Journal of Neurological Disorders

ISSN: 2329-6895

Journal of Neurological Disorders
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Visuospatial Deficit and Apraxia in Posterior Cortical Atrophy (PCA): a Single Case Follow-up Study

Lucio D'Anna*, Pier Luigi Dolso, Simone Lorenzut, Anna Perelli, Barbara Zanchettin, Mariarosaria Valente and Gian Luigi Gigli
Centre for Neurodegenerative Disorders, Neurology Clinic, University of Udine Medical School, Udine, Italy
Corresponding Author : Lucio D'Anna
Centre for Neurodegenerative Disorders
Neurology Clinic, University of Udine Medical School
Udine, Italy
Tel: 393492530016
E-mail: luciodanna@hotmail.it
Received May 06, 2014; Accepted June 05, 2014; Published June 08, 2014
Citation: D'Anna L, Dolso PL, Lorenzut S, Perelli A, Zanchettin B, et al. (2014) Visuospatial Deficit and Apraxia in Posterior Cortical Atrophy (PCA): a Single Case Follow-up Study. J Neurol Disord 2:166. doi: 10.4172/2329-6895.1000166
Copyright: © 2014 D'Anna L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google
Visit for more related articles at Journal of Neurological Disorders
 

Abstract

Posterior cortical atrophy (PCA) is a rare neurodegenerative syndrome characterized by insidious onset and selective, gradual decline in visuospatial and visuoperceptual skills.

We report a typical case of a patient with posterior cortical atrophy who presented initially with visuospatial deficit and apraxia. The aim of this report is to present this rare dementia subtype as a relevant differential diagnosis in respect to other neurodegenerative syndromes

Abstract
Posterior cortical atrophy (PCA) is a rare neurodegenerative syndrome characterized by insidious onset and selective, gradual decline in visuospatial and visuoperceptual skills.
We report a typical case of a patient with posterior cortical atrophy who presented initially with visuospatial deficit and apraxia. The aim of this report is to present this rare dementia subtype as a relevant differential diagnosis in respect to other neurodegenerative syndromes.
Introduction
Posterior cortical atrophy (PCA) is a rare neurodegenerative syndrome characterized by insidious onset and selective, gradual decline in visuospatial and visuoperceptual skills. Benson et al. in 1988 [1] for the first time described this rare but disabling dementia syndrome, in which visuo-spatial and visuo-perceptual impairments are the main clinical manifestations, often associated with alexia, prosopagnosia, environmental disorientation, features of Balint’s syndrome and Gerstmann’s syndrome [2]. Memory and verbal fluency are relatively well-preserved. Age at onset is typically before 65 years old [3].
Alzheimer’s disease (AD) seems to be the most common underlying cause of PCA, however it has been described in associations with Huntingtons’ disease, Lewy body dementia, Creutzfeldt-Jakob disease, cortico-basal degeneration and subcortical gliosis [4].
We report a typical case of a patient with PCA who presented initially with visuospatial deficit and apraxia. The aim of this report is to present this rare dementia subtype as a relevant differential diagnosis in respect to other neurodegenerative syndromes.
Case Summary
A 60-year-old right-handed woman was admitted to the Centre for Neurodegenerative Disorders, University of Udine, Italy, presenting progressive dyspraxic difficulties, deficits in writing and visuoperceptual problems since the last eight months.
At the age of 40 years, she was diagnosed as affected by breast tumour and underwent surgical intervention, followed by chemotherapy. Since the age of 45 has been treated for hypothyroidism.
Her family history was negative for any neurodegenerative condition, psychiatric disease or substance abuse. Her parents died at the age of 76 and 69 years, respectively, without cognitive deficits and his 77-year-old sister was still living and in good health.
The patient, who completed only the fifth grade of the elementary school, retired at the age of 58 years from her occupation as an industrial worker. Two years later, her husband reported the onset of mood deflection. In the last eight months she has progressively lost her ability to draw and write and developed problems with dressing, washing, using cutlery and handlings tools.
At admission, the neurological examination revealed signs of left visual neglect, optic ataxia and ocular apraxia. No alien limb phenomenon was documented. She scored 24/30 at Mini-Mental State Examination (MMSE).
Neuropsychological testing revealed severe ideomotor and ideational apraxia and visuospatial problems. The copy of a simple figure was impossible. Writing was impaired. Executive functions were compromised and a clear neglect was evident. Memory and fluent speech was intact, with a clear difficulty in naming tasks (Table 1).
Laboratory tests were within normal range. Structural neuroimaging demonstrated bilateral cortical atrophy, mainly located in the occipital and parietal lobes (Figure 1). Brain structural changes were confirmed by Single Photon Emission Computerized Tomography (99mTc SPECT), and extensive hypoperfusion in the parieto-occipito-temporal regions, mainly affecting the right hemisphere, was documented (Figure 2). Cerebrospinal (CSF) analysis was consistent with AD pattern, with decreased Ab42 (426 pg/mL, cutoff >500 pg/mL) and increased Tau (607 pg/mL, cut-off<350 pg/mL) and phospho-Tau (71 pg/mL, cut-off<60 pg/mL, as suggested by manufacturer, Kit-ELISA: Innotest Phospho-Tau) levels. Electroencephalography showed theta waves on posterior regions, bilaterally. In agreement with current clinical criteria, a diagnosis of PCA was made [5,6]. Namely, it was defined as biparietal variant according to the Alladi et al. classification [7]. The patient started therapy with transdermal rivastigmine (4.6 mg/24 h). At one-year follow-up, the neuropsychological examination showed that visuospatial praxis, writing and executive functions were significantly worsened. Language and verbal memory, largely preserved in the previous examination, were also significantly worsened (Table 1 and Figure 3A-3C). The patient had become totally dependent in her daily living activities.
Discussion
There is a growing number of reports of atypical focal cortical presentations of AD in patients with relatively younger onset, suggesting that diagnosis of AD needs to be considered even in patients who present with focal dementia without significant memory loss. Morevover, it is well established that the most frequent focal cortical presentations af AD are PCA, corticobasal syndrome (CBS), behavioural variant frontotemporal dementia (bvFTD), progressive non-fluent aphasia (PNFA) (or a mixed aphasia) and semantic dementia (SD) [7].
PCA is a focal cortical presentation of AD, atypical for its early age at onset and because a single cognitive domain, not related to memory, is predominantly affected [3].
Establishing clinical diagnosis of PCA involves a two-step process; at first, patients should meet basic criteria based on McMonagle et al. [5], and then they can be furtherly classified into three main variants: biparietal syndrome (apraxia, visuospatial problems, agraphia, Balint’s syndrome with preserved basic perceptual abilities, object recognition and reading), occipitotemporal syndrome (alexia, apperceptive agnosia and/or prosopagnosia) and visual variant (primary visual failure and impairment of basic perceptual abilities) [7].
We studied a 60-year patient with PCA and relatively short disease duration. Her clinical, cognitive and neuroradiologic findings indicate a predominantly right hemisphere dysfunction, resulting in dyspraxic difficulties, deficits in writing and impairment of visuo-spatial functions. Migliaccio et al. [8] showed that these deficits result from a selective posterior pattern of grey matter atrophy and from a damage to specific white matter pathways composing the visuo-spatial network.
CSF profile of the patient was typical for AD (characterized by alteration of ABeta42, t-tau and p-tau) [9]. The presence in our patient of the three pathological biomarkers of neurodegeneration confirm that in most in cases PCA can be considered a focal cortical variant of AD.
Previous literature studies support the hypothesis that a greater load of amyloid plaques and neurofibrillary tangles in the cerebral tissue are correlated with the earlier clinical symptoms of PCA patients and with the progressive cognitive decline [10,11], Since many patients with PCA show posterior neuritic plaques and neurofibrillary tangles at autopsy, the term PCA was often used interchangeably with AD or “the visual variant of AD.” [12]. Further studies showed the uniformity of the clinical profile of PCA, which is distinct from that of typical amnestic AD [5] and demonstrated that numerous conditions can mimic symptoms of PCA, including other types of progressive dementias, such as cortical basal syndrome (CBS), dementia with Lewy bodies and prion disease, in which presentation with apraxia and prominent visuospatial deficit is also common [13].
On the basis of these reports, this syndrome should be not considered exclusively a variant of AD, but rather a distinct nosologic entity with its behavioral profile dictated by the topography of pathology, more than its histology, and with its own diagnostic criteria.
Ruling out AD may also prevent inappropriate treatment, renouncing to use someone of the many medications available for AD, which are unnecessary for the conditions mimicking the symptoms of AD. Furthermore, whereas it is well known that a progressive amnestic syndrome in an elderly subject is highly predictive of AD pathology, in younger patients (under age 65) atypical, focal clinical syndromes which spare the long term memory may not evoke immediately the diagnosis of dementia disorder, and delay its correct treatment. For example, the visual variant of PCA can sometimes be misattributed to ocular causes, such as cataract or macular disease [11].
Our patient started therapy with transdermal rivastigmine (4,6 mg/24 h), and at one-year follow-up we observed a significant deterioration not only of the neuropsychological skills, but also in her daily living activities. Acetylcholinesterase inhibitors are usually reported as ineffective in the literature with, only a few cases suggesting some clinical benefits in PCA patients [14]. As far as we know, no clinical trials have been published.
In conclusion, our case report highlights the importance of making an accurate diagnosis of AD in clinical practice (and especially of ruling out AD) in order to reduce potentially inappropriate treatments which may slow the progression of the symptoms and disability of AD but are useless for other conditions [15].

References






















References






















Tables at a glance

image
Table 1

 

Figures at a glance

image   image   image
Figure 1   Figure 2   Figure 3
Select your language of interest to view the total content in your interested language
Post your comment
Share This Article
   
 
   
 
Relevant Topics
Disc ADHD
Disc Advance Treatment for Multiple Sclerosis
Disc Advanced Parkinson Treatment
Disc Advances in Alzheimers Therapy
Disc Alcohol Addiction
Disc Alcoholic Neuropathy
Disc Alzheimers Medicine
Disc Alzheimers Products & Market Analysis
Disc Alzheimers Symptoms
Disc Analytical Psychology
Disc Anxiety
Disc Bacteria Induced Neuropathies
Disc Bipolar Affective
Disc Bipolar Affective Disorders
Disc Bipolar Psychosis
Disc Brain Aneurysm
Disc Brain Infection
Disc Brain Injury Rehabilitation
Disc Brain Mapping
Disc Brain Rehabilitation
Disc Brain Scan
Disc Brain Stem Cell Therapy
Disc Brain Stimulation
Disc Brain Stroke
Disc Brain Structure and Function
Disc Brain Trauma/ Injury
Disc Brain Tumor
Disc CNS and Neurological Disorders
Disc Cerebral Palsy
Disc Childhood Anxiety
Disc Childhood Disorders
Disc Chronic Health Conditions
Disc Clinical Psychology
Disc Cognition
Disc Cognitive Disorders
Disc Cognitive Science
Disc Coma
Disc Convulsion
Disc Criminal Psychology
Disc Cultural psychology
Disc Degenerative Disorders
Disc Demyelination
Disc Depression
Disc Depression and Aging
Disc Diagnostic Alzheimer
Disc Disseminated Sclerosis
Disc DrugAddiction
Disc Dysthemia
Disc Educational Psychology
Disc Encephalitis
Disc Encephalomyelitis Disseminate
Disc Epilepsy
Disc Epilepsy neurorehabilitation
Disc Essential Tremor
Disc Evolutionary psychology
Disc Experimental Neurology
Disc Fungal Infection
Disc Germ cell tumours
Disc Health Promotion
Disc Health-Related Quality of Life
Disc Hippocampus
Disc Humanistic psychology
Disc Hydrocephalus
Disc Hypothalamus
Disc Immune-Mediated Disease
Disc Infectious Disease in Children
Disc Intellectual Disability
Disc Ischemic Stroke
Disc Limbic System
Disc Love Psychology
Disc Lyme
Disc Manic Despondency
Disc Manic-Depressive illness
Disc Medical Education
Disc Medical Rehabilitation
Disc Medical psychology
Disc Medicare
Disc Mental Disorder
Disc Mental Health Illiteracy
Disc Mental Health Morbidity
Disc Mental Health Needs
Disc Mental Health Services
Disc Mindfullness Based Therapy
Disc Mood Disorder
Disc Mood Disorders
Disc Motor Neuron Disease
Disc Multiple Sclerosis
Disc Multiple Sclerosis Diagnosis
Disc Multiple Sclerosis Physical Therapy
Disc Multiple sclerosis (MS) Medications
Disc Music psychology
Disc Myelin Repair
Disc Nerve Injury
Disc Neural Model
Disc Neuro Rehabilitation
Disc Neuro psychology
Disc Neuro-HIV and Bacterial Infection
Disc Neuro-Infections Induced Autoimmune Disorders
Disc Neurocystercercosis
Disc Neurocysticercosis
Disc Neurodegenerative Diseases
Disc Neurodegenerative Disorders
Disc Neuroepidemiology
Disc Neuroimmunological Disorders
Disc Neuroinfectious Agents
Disc Neurointensive Care
Disc Neurological Disabilities
Disc Neurological Physiotherapy
Disc Neurological Rehabilitation
Disc Neurological disorders
Disc Neuromuscular Disorders
Disc Neuromyelitis Optica
Disc Neuronal processing
Disc Neurooptometric Rehabilitation
Disc Neuropathy
Disc Neuropsychiatry
Disc Neurorehabilitation
Disc Neurorehabilitation Psychotherapy
Disc Neurorehabilitation and Neural Repair
Disc Neurosurgery
Disc Neurosurgical Emergencies
Disc Neurosyphilis
Disc Neurovirology
Disc Obsessive Compulsive Disorder
Disc OccupationalTherapy
Disc Panic Attacks
Disc Parkinson
Disc Parkinson's Disease
Disc Parkinsonism Diagnosis
Disc Parkinsonism Gene Therapy
Disc Parkinsonism Stages and Treatment
Disc Pathophysiology
Disc Pituitary
Disc Positive Psychology
Disc Post Traumatic Disorders
Disc Progressive Multifocal Leukoencephalopathy
Disc Pseudohypertrophic Myopathy
Disc Rare Infectious Disease
Disc Reverse Pyschology
Disc Seizure Disorder
Disc Shaking Palsy
Disc Social Anxiety Disorder
Disc Social Stigma
Disc Social psychology
Disc Spinal Cord
Disc Spinal Cord Injury Rehabilitation
Disc Spritual Psychology
Disc Stem cell Treatment Parkinson
Disc Stress Disorder
Disc Stroke Disorder
Disc StrokeRehabilitation
Disc Suicidal Thoughts
Disc Toxoplasmosis
Disc Traumatic Brain Injury
Disc Treatment Effects
Disc Viral Infection
Disc Yoga psychotherapy
 
Recommended Journals
Disc Mental Disorders and Treatment Journal
Disc Pediatric Neurosciences Journal
Disc PsychiatryJournal
Disc Depression and Anxiety Journal
Disc Multiple Sclerosis Journal
Disc Neuroinfectious Diseases Journal
Disc Neurorehabilitation Journal
Disc Brain Disorders & Therapy Journal
Disc Alzheimers Disease & Parkinsonism Journal
Disc Neurology & Neurophysiology Journal
  View More»
 
Recommended Conferences
Disc 4th Global Experts Meeting on Neuropharmacology
Sept 15-17, 2016 San Antonio, USA
Disc 5th Alzheimer’s Disease & Dementia Conference
Sept 29-Oct 1, 2016 London, UK
Disc International Psychiatric Mental Health
October 03-05, 2016 London, UK
Disc 2nd Brain Disorders Conference
Oct 17-29, 2016 Chicago, USA
Disc 10th International Conference on Nursing and Healthcare
December 05-07, 2016 Dallas, USA
 
Article Tools
Disc Export citation
Disc Share/Blog this article
 
Article usage
  Total views: 11419
  [From(publication date):
July-2014 - Aug 29, 2016]
  Breakdown by view type
  HTML page views : 7667
  PDF downloads :3752
 
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version